Palforzia™ (peanut [Arachis hypogaea] allergen powder-dnfp) – New drug approval
January 31, 2020 - The FDA announced the approval of Aimmune Therapeutics’ Palforzia (peanut [Arachis hypogaea] allergen powder-dnfp), for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut. Palforzia is approved for use in patients with a confirmed diagnosis of peanut allergy.
Top